Management of Knee Buckling in Patients with Diabetes and Neuropathy

Initial Diagnostic Evaluation

The American Diabetes Association recommends performing 10-g monofilament testing immediately to assess for loss of protective sensation, which is critical given the complaint of knee instability 1, 2
The American Diabetes Association suggests testing vibration sensation using a 128-Hz tuning fork to evaluate large-fiber function, as large-fiber neuropathy can cause proprioceptive deficits leading to knee buckling 1, 2
Assessment of temperature or pinprick sensation is recommended to evaluate small-fiber function 1, 2
Examination of lower extremity reflexes and muscle strength, particularly quadriceps strength, is necessary as weakness can directly cause knee buckling 1
Checking for orthostatic hypotension (drop in systolic BP >20 mmHg or diastolic BP >10 mmHg upon standing) is crucial, as this can contribute to knee buckling episodes 1, 2, 3
Assessing for resting tachycardia (>100 bpm) is important as a sign of cardiac autonomic neuropathy 2, 3

The American Diabetes Association recommends optimizing glucose control as the first-line intervention to slow progression of neuropathy in type 2 diabetes 2, 3
Target HbA1c should be individualized but generally <7% while avoiding hypoglycemia 2
Tight glycemic control is proven to slow neuropathy progression, though it does not reverse existing neuronal loss 2
Optimizing blood pressure control is recommended to reduce risk and slow progression of diabetic neuropathy 2
Optimizing serum lipid control is necessary as dyslipidemia is a key factor in neuropathy development in type 2 diabetes 2

Initiating structured physical therapy focusing on quadriceps strengthening is recommended, as quadriceps weakness is a major contributor to knee buckling in this population 4
Implementing balance training exercises is critical to compensate for proprioceptive deficits from large-fiber neuropathy 1

If neuropathic pain is present, initiating gabapentinoids (gabapentin or pregabalin), serotonin-norepinephrine reuptake inhibitors (duloxetine), tricyclic antidepressants, or sodium channel blockers is recommended as first-line agents 2
Reviewing current antihypertensive regimen if orthostatic hypotension is present is necessary, as this can contribute to knee buckling 3
ACE inhibitors or angiotensin receptor blockers are preferred in diabetic patients with neuropathy as they are metabolically neutral 5

The American Diabetes Association advises not to dismiss knee buckling as simply "weakness from age" - up to 50% of diabetic peripheral neuropathy may be asymptomatic, and this symptom indicates significant functional impairment requiring intervention 1, 3
The American Diabetes Association recommends not to delay neuropathy assessment - annual screening is required, but symptomatic patients need immediate evaluation 1, 2
Recognizing that knee buckling significantly increases fall risk and pain exacerbation is crucial, and this is not a benign symptom and requires aggressive management 1, 2
The American Diabetes Association suggests not to overlook autonomic neuropathy - orthostatic hypotension can masquerade as or contribute to knee instability 1, 2

Reassessing neuropathy status and knee stability at regular intervals (at least annually per guidelines, but more frequently given symptomatic presentation) is recommended 1, 2
Monitoring for development of foot ulcers given loss of protective sensation risk is necessary 1, 2